NF-κB and pancreatic cancer; chapter and verse
- Author(s)
- Silke, John; O’Reilly, Lorraine A;
- Details
- Publication Year 2021,Volume 13,Issue #18,Page 4510
- Journal Title
- Cancers
- Abstract
- Pancreatic Ductal Adenocarcinoma (PDAC) is one of the world’s most lethal cancers. An increase in occurrence, coupled with, presently limited treatment options, necessitates the pursuit of new therapeutic approaches. Many human cancers, including PDAC are initiated by unresolved inflammation. The transcription factor NF-κB coordinates many signals that drive cellular activation and proliferation during immunity but also those involved in inflammation and autophagy which may instigate tumorigenesis. It is not surprising therefore, that activation of canonical and non-canonical NF-κB pathways is increasingly recognized as an important driver of pancreatic injury, progression to tumorigenesis and drug resistance. Paradoxically, NF-κB dysregulation has also been shown to inhibit pancreatic inflammation and pancreatic cancer, depending on the context. A pro-oncogenic or pro-suppressive role for individual components of the NF-κB pathway appears to be cell type, microenvironment and even stage dependent. This review provides an outline of NF-κB signaling, focusing on the role of the various NF-κB family members in the evolving inflammatory PDAC microenvironment. Finally, we discuss pharmacological control of NF-κB to curb inflammation, focussing on novel anti-cancer agents which reinstate the process of cancer cell death, the Smac mimetics and their pre-clinical and early clinical trials.
- Publisher
- MDPI
- Keywords
- pancreatic cancer; PDAC; NF-κB; pancreatitis; inflammation; tumor microenvironment; therapy; Smac mimetics
- Research Division(s)
- Inflammation
- Publisher's Version
- https://doi.org/10.3390/cancers13184510
- Open Access at Publisher's Site
https://doi.org/10.3390/cancers13184510- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2021-09-17 11:23:25
Last Modified: 2021-09-17 11:59:26